Skip to main content
Log in

α2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase activity in heroin addicts in abstinence

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The inhibition of basal and forskolin-stimulated platelet adenylate cyclase activity by (-)adrenaline was studied in ten heroin addicts during spontaneous withdrawal. Both basal and forskolin-stimulated enzyme activities were increased during heroin withdrawal and the inhibitory effect induced by (-)adrenaline was potentiated with parallel shifts to the left of the concentration-effect curves. The number of binding sites for [3H](-)adrenaline in platelet membranes was also increased during withdrawal. Treatment with clonidine markedly attenuated the inhibitory effect induced by (-)adrenaline on platelet adenylate cyclase activity. The results indicate that the heroin withdrawal syndrome induces supersensitivity of the platelet α2-adrenoceptor-adenylate cyclase system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders (DSM III). APA, Washington, DC

    Google Scholar 

  • Bender JL, Wolf LG, Neer EJ (1984) Interaction of forskolin with resolved adenylate cyclase components. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:101–109

    Google Scholar 

  • Clare KA, Scrutton MC, Thompson NT (1984) Effects of α2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets. Br J Pharmacol 82:467–476

    Google Scholar 

  • Daly JW (1984) Forskolin, adenylate cyclase, and cell physiology: An overview. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:81–89

    Google Scholar 

  • Freedman JE, Aghajanian GK (1985) Opiate and α2-adrenoceptor responses of rat amygdaloid neurons: co-localization and interactions during withdrawal. J Neurosci 5:3016–3024

    Google Scholar 

  • García-Sevilla JA, Fuster MJ (1986) Labelling of human platelet α2-adrenoceptors with the full agonist [3H](-)adrenaline. Eur J Pharmacol 124:31–41

    Google Scholar 

  • García-Sevilla JA, Ulibarri MI (1986) Spontaneous morphine withdrawal modulates alpha-2 adrenoceptors in the rat brain. Br J Pharmacol 89:516P

    Google Scholar 

  • García-Sevilla JA, Hollingsworth PJ, Smith CB (1981) Alpha2 adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs. Eur J Pharmacol 74:329–341

    Google Scholar 

  • García-Sevilla JA, Ugedo L, Ulibarri I, Gutiérrez M (1985) Platelet α2-adrenoceptors in heroin addicts during withdrawal and after treatment with clonidine. Eur J Pharmacol 114:365–374

    Google Scholar 

  • Gold MS, Redmond DE Jr, Kleber HD (1978) Clonidine blocks acute opiate-withdrawal symptoms. Lancet II:599–602

    Google Scholar 

  • Hsu CY, Knapp DR, Haluska PV (1979) The effects of α-adrenergic agents on human platelet aggregation. J Pharmacol Exp Ther 208:366–370

    Google Scholar 

  • Jakobs KH, Saur W, Schultz G (1976) Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. J Cyclic Nucleotide Protein Phosphorylation Res 2:381–392

    Google Scholar 

  • Klee WA, Sharma SK, Nirenberg M (1975) Opiate receptors as regulators of adenylate cyclase. Life Sci 16:1869–1874

    Google Scholar 

  • Kuriyama K (1982) Central β-adrenergic receptor-adenylate cyclase system and formation of morphine withdrawal syndrome. TIPS 3:473–476

    Google Scholar 

  • Lasch P, Jakobs KH (1979) Agonistic and antagonistic effects of various α-adrenergic agonists in human platelets. Naunyn-Schmiedeberg's Arch Pharmacol 306:119–125

    Google Scholar 

  • Lowry OH, Rosebrough NF, Farr AG, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  • Mehrishi JN, Mills IH (1983) Opiate receptors on lymphocytes and platelets in man. Clin Immunol Immunopathol 27:240–249

    Google Scholar 

  • Minneman KP, Hegstrand LR, Molinoff PB (1979) The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol Pharmacol 16:21–33

    Google Scholar 

  • Pandey GN, De Leon-Jones FA, Inwang EE, Davis JM (1980) Effect of acute methadone withdrawal on prostaglandin E-stimulated 3H-cyclic adenosine monophosphate accumulation in human platelets. Clin Pharmacol Ther 27:607–611

    Google Scholar 

  • Salomon Y (1979) Adenylate cyclase assay. Adv Cyclic Nucleotide Protein Phosphorylation Res 10:35–55

    Google Scholar 

  • Salomon Y, Londos C, Rodbell M (1974) A highly sensitive adenylate cyclase assay. Anal Biochem 58:541–548

    Google Scholar 

  • Schoffelmeer ANM, Putters J, Mulder AH (1986) Activation of presynaptic α2-adrenoceptors attenuates the inhibitory effect of μ-opioid receptor agonists on noradrenaline release from brain slices. Naunyn-Schmiedeberg's Arch Pharmacol 333:377–380

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

García-Sevilla, J.A., Ulibarri, I., Ugedo, L. et al. α2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase activity in heroin addicts in abstinence. Psychopharmacology 92, 320–323 (1987). https://doi.org/10.1007/BF00210837

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00210837

Key words

Navigation